Evidence map›Paper›PMID 40330833›Full record

ArticleFrontiers in oncology2025

Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis.

Yuxiang Sun, Junpeng Xu, Dongsheng Kong, Yu Zhang, Qijia Wu, Liqin Wei, Zihao Zhu, Chunhui Li, Shiyu Feng

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuxiang Sun *Department of Neurosurgery, Affiliated Hospital of Hebei University, Baoding, China.
Junpeng Xu *Department of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Dongsheng Kong *Department of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yu ZhangDepartment of Neurosurgery, Xuanwu Hospital, Xiongan, China.
Qijia WuDepartment of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Liqin WeiDepartment of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Zihao ZhuDepartment of Neurosurgery, Affiliated Hospital of Hebei University, Baoding, China.
Chunhui LiDepartment of Neurosurgery, Affiliated Hospital of Hebei University, Baoding, China.
Shiyu FengDepartment of Neurosurgery, the First Medical Center of Chinese PLA General Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Accurate preoperative identification of intracranial glioblastoma (GB), primary central nervous system lymphoma (PCNSL), and brain metastases (BM) is crucial for determining the appropriate treatment strategy. Purpose: We aimed to develop and validate the utility of preoperative magnetic resonance imaging-based radiomics and machine learning models for the noninvasive identification them. STUDY TYPE: Retrospective. POPULATION: We included 202 patients, including 71 GB, 59 PCNSL, and 72 BM, randomly divided into a training cohort (n =141) and a validation cohort (n = 61).FIELD STRENGTH/SEQUENCE: Axial T2-weighted fast spin-echo sequence (T2WI) and contrast-enhanced T1-weighted spin-echo sequence (CE-T1WI) using 1.5-T and 3.0-T scanners. ASSESSMENT: We extracted radiomics features from the T2 sequence and CE-T1 sequence separately. Then, we applied the F-test and recursive feature elimination (RFE) to reduce the dimensionality for both individual sequences and the combined sequence CE-T1 combined with T2.The support vector machine (SVM), k-nearest neighbor (KNN), and naive Bayes classifier (NBC) were used in model development. STATISTICAL TESTS: Chi-square test, one-way analysis of variance, and Kruskal-Wallis test were performed. The P values <0.05 were considered statistically significant. Performance was evaluated using AUC, sensitivity, specificity, and accuracy metrics. Result: The SVM model exhibited superior diagnostic performance with macro-average AUC values of 0.91 for CE-T1 alone, 0.86 for T2 alone, and 0.93 for combined CE-T1 and T2 sequences. And the combined sequence model demonstrated the best overall accuracy, sensitivity, and F1 score, with an accuracy of 0.77, outperforming both KNN and NBC models. Conclusion: The SVM-based MRI radiomics model effectively distinguishes between GB, PCNSL, and BM. Combining CE-T1 and T2 sequences significantly enhances classification performance, providing a robust, noninvasive diagnostic tool that could assist in treatment planning and improve patient outcomes.

Indexed as

central nervous system malignant tumorsglioblastomamachine learningmagnetic resonance imaging; multi-classificationPCNSL = primary CNS lymphoma

Identifiers

PMID40330833
PMCPMC12052887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.